SFD:NASDAQSmithfield Foods, Inc. Analysis
Data as of 2026-05-26 - not real-time
$26.34
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Smithfield Foods trades near its short‑term moving averages with a neutral RSI and a modest bullish MACD histogram, suggesting limited immediate price pressure. Technical support sits just below the current level, while resistance remains near the recent high. The stock offers a dividend yield close to five percent and a payout ratio comfortably below half of earnings, indicating strong cash‑flow coverage. Fundamentally, revenue growth is flat and margins are modest, reflecting the low‑growth nature of the packaged‑meats segment. However, the company’s balance sheet is solid, with low leverage and ample cash to sustain dividends. The market price exceeds the discounted cash‑flow estimate, implying that the stock may be priced for optimism, yet analyst consensus still leans bullish.
Looking ahead, the defensive consumer‑staples positioning provides resilience amid economic uncertainty, and the low beta underscores limited systematic risk. The recent dividend declaration reinforces shareholder‑friendly policy, while decreasing volume hints at waning short‑term enthusiasm. Analysts project a target price well above the current level, suggesting upside potential if valuation pressures ease. Nonetheless, modest growth prospects and a relatively high volatility profile temper expectations. Investors should weigh the attractive yield against the premium to intrinsic value when forming a position.
Looking ahead, the defensive consumer‑staples positioning provides resilience amid economic uncertainty, and the low beta underscores limited systematic risk. The recent dividend declaration reinforces shareholder‑friendly policy, while decreasing volume hints at waning short‑term enthusiasm. Analysts project a target price well above the current level, suggesting upside potential if valuation pressures ease. Nonetheless, modest growth prospects and a relatively high volatility profile temper expectations. Investors should weigh the attractive yield against the premium to intrinsic value when forming a position.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Neutral technical indicators with modest bullish bias
- Strong dividend yield supporting income focus
- Current price above DCF fair value limiting upside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst target price indicating upside potential
- Defensive sector and low beta offering stability
- Sustainable dividend enhancing total return
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Stable cash flows and low leverage supporting dividend continuity
- Limited growth prospects in a mature industry
- Valuation premium relative to intrinsic value
Key Metrics & Analysis
Financial Health
Revenue Growth0.80%
Profit Margin6.49%
P/E Ratio10.2
ROE14.95%
ROA7.29%
Debt/Equity33.30
P/B Ratio1.5
Op. Cash Flow$1.2B
Free Cash Flow$630.4M
Technical Analysis
TrendNeutral
RSI49.7
Support$24.63
Resistance$29.35
MA 20$26.12
MA 50$26.68
MA 200$24.13
MACDBullish
VolumeDecreasing
Fear & Greed Index91.64
Valuation
Fair Value$19.04
Target Price$31.36
Upside/Downside19.05%
GradeFair
TypeValue
Dividend Yield4.75%
Risk Assessment
Beta0.19
Volatility28.26%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.